# Value of Biological Age, in Addition to Individual Frailty, for Personalising the Management of Cancer Treated with Targeted Therapy

> **NCT06130787** · NA · RECRUITING · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 321 (estimated)

## Conditions studied

- Leukemia,Myeloid, Chronic

## Interventions

- **BIOLOGICAL:** Blood and bone marrow sample

## Key facts

- **NCT ID:** NCT06130787
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-17
- **Primary completion:** 2025-11-17
- **Final completion:** 2028-11-17
- **Target enrollment:** 321 (ESTIMATED)
- **Last updated:** 2024-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06130787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06130787, "Value of Biological Age, in Addition to Individual Frailty, for Personalising the Management of Cancer Treated with Targeted Therapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06130787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*